Daiichi Sankyo Suspends Marketing ActHIB Flu Shots For Kids
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo said a possible foreign substance in a pair of syringes has led to a recall of 13 lots of its ActHIB, pediatric flu vaccine from the Japanese market